Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Principia Biopharma reports TXK and ITK inhibitors

Sep. 30, 2015

Department of Health of the U.K. and JNCASR describe antimicrobial conjugates

Sep. 30, 2015

IURTC and Assembly Biosciences patent HBV core protein allosteric modulators

Sep. 30, 2015

FORUM Pharmaceuticals presents gamma-secretase modulators

Sep. 29, 2015

Icahn School of Medicine at Mount Sinai describes PP2A activators

Sep. 29, 2015

AbbVie Deutschland discloses 5-HT2C receptor agonists

Sep. 29, 2015

Takeda Pharmaceutical reports development of acyl-CoA desaturase inhibitors

Sep. 29, 2015

Columbia University in the City of New York patents MOR-1 agonists

Sep. 29, 2015

A*STAR develops HDAC inhibitors

Sep. 28, 2015

Chong Kun Dang Holdings discloses HDAC6 inhibitors

Sep. 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...